Published
Containing bacterial resistance. An approach based on the nursing practice
Contención de la resistencia bacteriana. Un enfoque desde la enfermería
Contenção da resistência bacteriana. Uma abordagem desde a enfermagem
Keywords:
drug resistance bacterial, cross infection, anti-bacterial agents, nursing, dosage forms (en)farmacorresistencia bacteriana, infección hospitalaria, antibacterianos, enfermería, formas de dosificación (es)
farmacorresistência bacteriana, infecção hospitalar, antibacterianos, enfermagem, formas de dosagem (pt)
Downloads
Purpose. To highlight the role of the nursing professional in containing the generation of antibiotic-resistant bacteria, through safe practices in the administration of antibiotics.
Methodology. Approximately 1,200 publication of biomedical research were verified from the data base of the Medline, Highwire, Docement, among others.
Results. It was verified that the inadequate use of medicines along with wrong practices to control infections in hospitals, inappropriate therapeutical schemes, lack of adherence to antibiotics administration protocols by the nursing professional has largely caused the increase of bacterial resistance.
Discussion. Control of infectious diseases is currently harder to achieve as a consequence of the increase of the bacterial resistance to antimicrobials, which are those with greater incidence in the development of the infections.
Resolution WHA51.171 of the World Health Organization of 1998 proposes to implement a strategy to improve the access and use of antimicrobials, which contributes to containing the emergence of resistant bacteria.
Conclusions. The implementation of strategies for the use of antibiotics by the nursing professional, concerning the application of safe management protocols in the administration of antibiotics becomes an input that can be used to stop the emergence and spreading of resistant bacteria in infections related to health care.
Objetivo. Destacar el papel que el profesional de enfermería ejerce para contener la generación de bacterias resistentes a los antibióticos, mediante prácticas seguras en la administración de estos.
Metodología. Se revisaron aproximadamente 1200 publicaciones de investigación biomédica en la base de datos del Medline, Highwire, Docemet, entre otras.
Resultados. Se encontró que la utilización inadecuada de medicamentos con prácticas incorrectas para controlar infecciones en los hospitales, el inapropiado régimen terapéutico, la falta de adherencia a los protocolos en la administración de antibióticos, por parte del profesional de enfermería, han llevado en gran medida al incremento de la resistencia bacteriana.
Discusión. El control de las enfermedades infecciosas, en la actualidad, es más difícil de lograr como consecuencia del aumento de la resistencia bacteriana a los antimicrobianos, que son los que tienen una mayor incidencia en el desarrollo de estas infecciones.
La Resolución WHA51.171 de la Asamblea Mundial de la Salud de 1998, OMS, propone, como estrategia, mejorar el acceso y la utilización de los antimicrobianos, lo que contribuye a contener la aparición de bacterias resistentes.
Conclusiones. La implementación de estrategias para el uso de los antibióticos, por parte del profesional de enfermería, en relación con la aplicación de los protocolos de manejo seguros en la administración de los antibióticos, se convierte en un aporte que desde la profesión se puede efectuar para contener el surgimiento y la diseminación de bacterias resistentes en las infecciones asociadas al cuidado de la salud.
Objetivo. Destacar o papel que o profissional de enfermaria exerce para conter a geração de bactérias resistentes aos antibióticos, mediante práticas seguras na administração destes.
Metodologia. Revisaram-se aproximadamente 1200 publicações de pesquisa biomédica na base de dados do Medline, Highwire, Docemet, entre outras.
Resultados. Encontrou-se que a utilização inadequada de medicamentos com práticas incorretas para controlar infecções nos hospitais, o inapropriado regime terapêutico, a falta de aderência aos protocolos na administração de antibióticos por parte do profissional de enfermagem, causará em grande medida o incremento da resistência bacteriana.
Discussão. O controle das doenças infecciosas, na atualidade, é mais difícil de alcançar como consequência do aumento da resistência bacteriana aos antimicrobianos, que são os que têm uma maior incidência no desenvolvimento destas infecções.
A resolução WHA51.171 da Assembleia Mundial da Saúde de 1998, OMS, propõe como estratégia, melhorar o aceso e a utilização dos antimicrobianos, o que contribui a conter a aparição de bactérias resistentes. Conclusões. A implementação de estratégias para o uso dos antibióticos por parte do profissional da enfermagem, em relação à aplicação dos protocolos de manejo seguro na administração dos antibióticos, transforma-se em um contributo que desde a profissão se pode efetuar para conter o surgimento e a disseminação de bactérias resistentes nas infecções associadas ao cuidado da saúde.
References
(1)Ríos C. Legislación sobre antibióticos en América Latina. Washington. EUA: Organización Panamericana de la Salud; 2004. 119 p.
(2)Barcenilla F, Jover A, Castellana D, López R. Control de la infección nosocomial. Una visión más allá de cuidados intensi-vos. En: Net A, Quintana E, editores. Infecciones en medicina intensiva. Barcelona: Ars Medica; 2007. p. 19-28
(3)Jarvis W. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med. 1991;91:185S-191S.
(4)Cosgrove S. The relationship between antimicrobial re-sistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82-S89.
(5)Raymond D, Pelletier S, Crabtree T, Evans H, Pruett T, Sawyer R. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med. 2003;31:1035-41.
(6)Zhan C, Miller M. Excess length of stay, charges, and mortality attributable to medical injuries during hospitaliza-tion. J Ame Med Assoc. 2003;290(14):1868-74.
(7)Paladino J, Sunderlin J, Price C, Schentag J. Econom-ic consequences of antimicrobial resistance. Surg Infect. 2002;3(3):259-67.
(8)Sánchez L, Ríos R, Máttar S. Detección de β-lactamasas de espectro extendido en Escherichia coli y Klebsiella pneu-moniae aislados en una clínica de Villavicencio, Colombia. In-fectio 2008;12(3):193-200.
(9)Martínez P. Aislamientos de P. aeruginosa y A. bauman-nii productores de metalo-β-lactamasas en un hospital de Co-lombia: Prevalencia y características fenotípicas asociadas con la resistencia a carbapenemes. Infectio. 2004;8(2):127.
(10)Patton K. Role of JCAHO Standards and clinical practice guidelines in promoting appropriate antimicrobial use. J Ame Health Syst. 2002; 59(Suppl 3):S16-S18.
(11)Nightingale F. Notas sobre enfermería. ¿Qué es y qué no es enfermería? [Notes of Nursing. ¿What it is and what it is not?]. Barcelona: Salvat Editores; 1990. 139 p.
(12)Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS, National Nosocomial Infections Surveillance Sys-tem. Surgical Site Infection (SSI) Rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System Basic SSI Risk Index. Clin Infect Dis. 2001;33(Suppl 2):S69-S77.
(13)Mertens R, BergJ, Fabry J, Jepsen O. Helics: un pro-yecto europeo para la estandarización de la vigilancia de infec-ciones adquiridas en hospitales, 1994-1995. Eurosurveillance. 1996 Abr;4:1.
(14)Secretaría Distrital de Salud de Bogotá. Boletín Epide-miológico de Resistencia Bacteriana (SIVIBAC) 2008–2009. [en línea]. Bogotá D.C.: Secretaria Distrital de Salud de Bogo-tá; 2008.
(15)Centro Internacional de Entrenamiento e Investigacio-nes Médicas (Cideim). Santiago de Cali, Colombia. 2012.
(16)Universidad Nacional de Colombia, Grebo - Grupo de Estudio de la Resistencia Bacteriana en Bogotá [internet]. Bo-gotá D.C.: grebo.org; 2011.
(17)Red de Vigilancia de Eventos Nosocomiales del Valle (Renova) [página en Internet]. Santiago de Cali, Colombia. Di-posnible en: http://renova.org.co/sitio
(18)Grupo para el Estudio de la Resistencia a Antibióticos de Medellín (Germen). Programa de Vigilancia de Resistencia Bacteriana en Antioquia. Medellín: Colombia. Disponible en: http://www.grupogermen.org/germen%20blur1.swf
(19)Ibrahim E, Sherman G, Ward S, Fraser V, Kollef M. The influence of inadequate antimicrobial treatment of bloods-tream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-55.
(20)Kollef M, Sherman G, Ward S, Fraser V. Inadequate an-timicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-74.
(21)Bodi M, Diaz E, Rello J. Appropriate antibiotic treatment for pneumonia. Clin Infect Dis. 2000;31:1313-14
(22)Pinder M, Bellomo R, Lipman J. Pharmacological prin-ciples of antibiotic prescription in the critically ill. Anaesth In-tensive Care. 2002;30:134-44.
(23)Blot S, Depuydt P, Vandewoude K, DeBacquer D. Mea-suring the impact of multidrug resistance in nosocomial infec-tion. Curr Opin Infect Dis. 2007;20:391-6.
(24)Sader H. Antimicrobial Resistance. How are we? Rev Chil Infectol. 2002;19:S1.
(25)Gomes AR, Sanches I, Aires De Sousa M, Castaneda E, De Lencastre H. Molecular epidemiology of methicillin-resis-tant Staphylococcus aureus in Colombian hospitals: Dom-inance of a single unique multidrug- resistant clone. Microb Drug Resist. 2001;7:23-32.
(26)Leal A, Eslava J, Álvarez C, Buitrago G, Méndez M, Gre-bo. Canales endémicos y marcadores de resistencia bacteriana, en instituciones de tercer nivel de Bogotá, Colombia. Rev Salud Pública. 2006;8(Supl 1):59-70.
(27)Suárez C, Kattán J, Guzmán A, Villegas M. Mecanismos de resistencia a carbapenems en P. aeruginosa, Acinetobactery Enterobacteriaceae y estrategias para su prevención y con-trol. Infectio. 2006;10:85-93.
(28)Lucet J, Chevret S, Decré D, Vanjak D, Macrez A, Bédos J, et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acqui-sition. Clin Infect Dis. 1996;22:430-6.
(29)Chambers H. The changing epidemiology of Staphylo-coccus aureus? Emerg Infect Dis. 2001;7:178-82.
(30)Gould, I. The clinical significance of methicillin-resis-tant Staphylococcus aureus. J Hosp Infect. 2005;61:277-82.
(31)Herold B, Immergluck L, Maranan M, Lauderdale D, Gaskin R, Boyle-Vavra S, et al. Community acquired methici-llin-resistant Staphylococcus aureus in children with no iden-tified predisposing risk. J.Ame. Med. Assoc. 1998;279:593-8.
(32)Udo E, Pearman J, Grubb W. Genetic analysis of com-munity isolates of methicillin-resistant Staphylococcus aureusin Western Australia. J Hosp Infect. 1993;25:97-108.
(33)Uttley A, Collins C, Naidoo J, George R. Vancomycin-re-sistant Enterococci. Lancet. 1998;1:57-8.
(34)Villegas MV, Lolans K, Correa A, Suarez CJ, López JA, Vallejo M, et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneu-monia from South America. Antimicrob Agents Chemother. 2006;50:2880-2.
(35)Villegas MV, Correa A, Perez F, Zuluaga T, Radice M, Gutkind G, et al. Detection of CTX-M-12 -lactamase in a Kleb-siella pneumoniae clinical isolate in Colombia. Antimicrob Agents Chemother. 2004;48:629-31.
(36)Crespo MP, Woodford N, Sinclair A, Kaufmann KE, Turton J, Glover J, et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metal-lo-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol. 2004;42:5094-101.
(37)Villegas MV, Kattan JN, Correa A, Lolans K, Guzman AM, Woodford N, et al. Dissemination of Acinetobacter bau-mannii clones with OXA-23 carbapenemase in Colombian Hospitals. Antimicrob Agents Chemother. 2007;51(6):2001-4.
(38)Gastmeier P, Sohr D, Geffers C, Behnke M, Ruden H. Risk factors for death due to nosocomial infection in intensive care unit patients: findings from the Krankenhaus Infections Surveillance System. Infec. Control Hosp. Epi. 2007;28:466-72.
(39)Johnston CP, Stokes AK, Ross T, Cai M, Carroll KC, Cosgrove SE, et al. Staphylococcus aureus colonization among healthcare workers at a tertiary care hospital. Infec. Control Hosp. Epi. 2007; 28:1404-7.
(40)Beezhold D, Slaughter S, Hayden M, Matushek M, Na-than C, Trenholme G, et al. Skin colonization with vancomy-cin- resistant Enterococci among hospitalized patients with bacteremia. Clin Infect Dis. 1997;24:704-6.
(41)Livornese L, Dias S. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117:112-6.(42)Sheretz R, Sullivan M. An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients’ mattresses. J Infect Dis. 1985;151:252-8.
(43)Jawed A, Seifert H, Snelling A, Heritage J, Hawkey P. Survival of Acinetobacter baumannii on dry surfaces: com-parison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36:1938-41.
(44)Pfaller M, Jones R, Doern G, Kugler K. Bacterial patho-gens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY-surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother. 1998;42:1762-70.
(45)Fabbro-Peray P, Sotto A, Defez C, Cazaban M, Molinari L, Pinede M. Mortality attributable to nosocomial infection: A cohort of patients with and without nosocomial infection in a French university hospital. Infec. Control Hosp. Epi. 2007;28:265-72.
(46)Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect. 2008;14:5-13.
(47)Rello J, Gallego M, Mariscal D, Soñora R, Valles J. The value of routine microbiogical investigation in ventila-tor-associated pneumonia. Am. J. Respir. Crit. Care Med. 1997;156:196-200.
(48)Luna C, Vujacich P, Niederman M, Vay C, Gherardi C, Matera J, et al. Impact of BAL data on the therapy and out-come of ventilator associated pneumonia. Chest. 1997;111:676-85.
(49)Alvarez F, ICU Acquired Pneumonia Study Group. Mod-ification of empiric antibiotic treatment in patients with pneu-monia acquired in the intensive care unit. Intensive Care Med. 1996;22:387-94.
(50)American Thoracic Society. Hospital acquired pneu-monia in adults: diagnosis, assessment of severity, initial an-timicrobial therapy and preventative strategies. Am. J. Respir. Crit. Care Med. 1995;153:1711-25.
(51)Jacobson C, Strausbaugh L. Incidence and impact of infection in a nursing home care unit. Am. J. Infect. Control. 1990;18:151-9.
(52)Wayne S, Rhyne R, Stratton M. Longitudinal prescrib-ing patterns in a nursing home population. J Am Geriatr Soc. 1992;40:53-6.
(53)Hoffman N, Jenkins R, Putney K. Nosocomial infection rates during a one-year period in a nursing home care unit of a veterans administration hospital. Am. J. Infect. Control. 1990;18:55-63.
(54)Strausbaugh L, Rello J, Sa-Borges M, Correa H, Leal S, Baraibar J. Variations in aetiology of ventilator-associated pneumonia across four treatment sites. Implications for anti-microbial prescribing practices. Am. J. Respir. Crit. Care Med. 1999;160:608-13.
(55)Eggimann P, Pittet D. Infection control in the ICU. Chest. 2001;120(6):2059-93.
(56)Centers for Disease Control and Prevention. Monitoring hospital-acquired infections to promote patient safety—United States, 1990-1999. Morb. Mort. Weekly Rep. 2000;49(9):189-90.
(57)Boyce J, Pittet D. Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hy-giene Task Force. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Con-trol Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J. Infect. Control. 2002;30(8):S1-S46.
(58)República de Colombia. Ley 266 de 1996, por la cual se reglamenta la profesión de enfermería en Colombia, Congreso de la República, Diario Oficial (25 Ene 1996).
(59)Carrillo GM. Evidencias que utilizan las enfermeras que participan en comités de infecciones para la toma de decisio-nes. Av Enferm. 2007;XXV(1):83-91.
(60)Organización Mundial de la Salud. Guía práctica para la prevención de infecciones nosocomiales. 2ª edición. New York: OMS; 2003.
(61)The United States Pharmacopeial Convention. USP34 – NF29: Farmacopea de los Estados Unidos de América - For-mulario Nacional. Volumen 1. Rockville, Maryland: The Uni-ted States Pharmacopeial Convention; 2011.
(62)Pharmacokinetics and Pharmacodynamics of Antinfec-tive Agents. En: Mandel, D. Benett ́s principles and practice of infectious diseases. Volume 1. 6th edition. Philadelphia, Penn-sylvania: Elsevier Churchill Livingstone; 2005. 276 p.
(63)Mouton J, Vinks A. PK-PD modelling of antibiotics in vitro and in vivo using bacterial growth and kill kinetics: the MIC vs stationary concentrations. Clin Pharmacokinet. 2005;44:201-10.
(64)Bradley JS, Garau J, Lode H, Rolston KVI, Wilson SE, Quinn JP. Carbapenems in clinical practice: A guide to their use in serious infection. Int J Antimicrob Agents. 1999;11:93-100.
(65)Freeman CD, Nicolau DP, Belliveau PP; Nightingale CH. Once-daily dosing of aminogylcosides: Review and recommen-dations for clinical practice. J Antimicrob Chem. 1997;39:677-86.
(66)Karlowsky J, Zhanel G, Davidson R. Once-daily ami-noglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1994;38:1165-8.
(67)Lami JL, Wilson SE, Hopkins JA. Adjuntive antimicro-bials in surgery of soft tissue infections: Evaluations of cepha-losporins and carbapenems. Ame J Surg. 1991;57:769-74.
(68)Levison ME, Bush LM. Pharmacodynamics of antimi-crobial agents: Bacterials an postantibiotic effects. Inf. Dis. Clin. North Am. 1989;3:415-21.
(69)Lodise T, Lomaestro B, Drusano G. Piperacillin-ta1zo-bactam for Pseudomonas aeruginosa infection: Clinical impli-cations of an extended-infusion dosing strategy. Clin. Infect. Dis. 2007;44:357-63.
(70)Moore R, Lietman P, Smith C. Clinical response to ami-noglycoside therapy: Importance of the ratio of peak concen-tration to minimum inhibitory concentration. J. Infect. Dis. 1987;155:93-8.
(71)Mouton J, Vinks A. Continuous infusion of beta-lactams. Curr. Opin. Crit. Care. 2007;13:598-606.
(72)Sprauten PF, Beringe PM, Louie SG, Synold TW, Mark AG. Temperature stability and antibacterial activity of cefepime during continuous infusion administration. In: Program and Abstracts of the 42nd Interscience Conference on Antimicro-bial Agents and Chemotherapy. San Diego, CA: 2002. Abstract A-1400.
(73)Tam VH, Gamez EA, Weston JS, Gerard LN, Larocco MT, Caeiro JP, et al. Outcomes of bacteremia due to Pseudo-monas aeruginosa with reduced susceptibility to Piperacil-lin-Tazobactam: Implications on the appropriateness of the resistance breakpoint. Clin. Infect. Dis. 2008;46:862-7.
Article abstract page views
Downloads
How to Cite
License
Copyright (c) 2012 Avances en Enfermería
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published by Avances en Enfermería are licensed under the Creative Commons Attribution 4.0 International License. Starting 2020, we added the CC-BY-NC recognition to the license, which means anyone is allowed to copy, redistribute, remix, transmit and transform our contents with non-commercial purposes, and although new works must adequately cite the original work and source and also pursue non-commercial purposes, users do not have to license derivative works under the same terms.
